As of June 21, 2025, Anthera Pharmaceuticals Inc (ANTH) reports a Net Margin of -38291.72%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Anthera Pharmaceuticals Inc's Net Margin
Over recent years, Anthera Pharmaceuticals Inc's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2017-12-31 | -38291.72% |
| 2016-12-31 | -38291.72% |
| 2015-12-31 | -1105.81% |
This fluctuation highlights how Anthera Pharmaceuticals Inc manages its overall profitability and cost control over time.
Comparing Anthera Pharmaceuticals Inc's Net Margin to Peers
To better understand Anthera Pharmaceuticals Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Anthera Pharmaceuticals Inc (ANTH) | -38291.72% |
| Many Bright Ideas Technologies Inc (MBI.H.V) | 73.91% |
| Capstone Holding Corp (CAPS) | 13.89% |
| HST Global Inc (HSTC) | -6.47% |
| FluoroPharma Medical Inc (FPMI) | -11.76% |
| Sophiris Bio Inc (SPHS) | -223.00% |
Compared to its competitors, Anthera Pharmaceuticals Inc's Net Margin is among the lowest compared to peers, which may indicate challenges in controlling expenses or competitive pricing pressures.